Gilead Sciences (GILD) Tax Rate (2009 - 2026)
Gilead Sciences (GILD) reported Tax Rate of 21.67% for Q1 2026, up 141.0% on a YoY basis from 8.99% in Q1 2025, and up 200.05% quarter-over-quarter from 21.66% in Q4 2025.
Gilead Sciences (GILD) Tax Rate (2009 - 2026) Analysis & Trends
Gilead Sciences has reported Tax Rate for 18 years, with the latest figure at 21.67% in Q1 2026.
- For the quarter ending Q1 2026, Tax Rate rose 141.0% year-over-year to 21.67%; the trailing twelve-month figure through Mar 2026 stood at 10.87% (down 173.0% YoY), and the FY2025 full-year result was 13.13%, down 1745.0% from the prior year.
- Tax Rate for Q1 2026 stood at 21.67%, up from 21.66% in the prior quarter.
- The five-year high for Tax Rate was 107.89% in Q1 2022, with the low at 31.07% in Q3 2024.
- Historically, Tax Rate has averaged 19.34% across 5 years, with a median of 19.6% in 2022.
- Annual changes were most pronounced in 2022 — Tax Rate soared 8395 bps — and 2023, when it slumped 8359 bps.
- Gilead Sciences' Tax Rate stood at 19.6% in 2022, then dropped by 27 bps to 14.34% in 2023, then increased by 24 bps to 17.77% in 2024, then plunged by 222 bps to 21.66% in 2025, then jumped by 200 bps to 21.67% in 2026.
- The last three Tax Rate figures came in at 21.67% (Q1 2026), 21.66% (Q4 2025), and 16.18% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | -14.23 |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | 16.43 |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 12.60 |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | 32.92 |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | -20.26 |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | 12.72 |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 21.67 |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | 14.54 |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | 17.31 |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.67% |
| Mar 31, 2026 | 21.67% |
| Dec 31, 2025 | -21.66% |
| Dec 31, 2025 | -21.66% |
| Sep 30, 2025 | 16.18% |
| Sep 30, 2025 | 16.18% |
| Jun 30, 2025 | 19.27% |
| Jun 30, 2025 | 19.27% |
| Mar 31, 2025 | 20.25% |
| Mar 31, 2025 | 20.25% |
| Dec 31, 2024 | 17.77% |
| Dec 31, 2024 | 17.77% |
| Sep 30, 2024 | -31.07% |
| Sep 30, 2024 | -31.07% |
| Jun 30, 2024 | 21.33% |
| Jun 30, 2024 | 21.33% |
| Mar 31, 2024 | 7.02% |
| Mar 31, 2024 | 7.02% |
| Dec 31, 2023 | 14.34% |
| Dec 31, 2023 | 14.34% |